Skip to main content

Table 1 PinX1 staining and clinicopathological characteristics of 405 breast cancer patients

From: PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway

Variables PinX1 staining
Low (%) High (%) Total P *
Age     
≤50 years 99 (52.7) 89 (47.3) 188 0.906
>50 years 113 (52.1) 104 (47.9) 217  
Tumor size     
T1 (<2 cm) 47 (61.8) 29 (38.2) 76 0.090
T2 (2-5 cm) 148 (51.2) 141 (48.8) 289  
T3 (>5 cm) 11 (39.3) 17 (60.7) 28  
Lymph node metastasis     
Negative 83 (43.5) 108 (56.5) 191 0.002
Positive 110 (59.5) 75 (40.5) 185  
Histology grade     
I 11 (30.6) 25 (69.4) 36 0.001
II 103 (50.5) 101 (49.5) 204  
III 50 (68.5) 23 (31.5) 73  
ER status     
Negative 40 (54.8) 33 (45.2) 73 0.359
Positive 63 (48.1) 68 (51.9) 131  
PR status     
Negative 48 (54.5) 40 (45.5) 88 0.313
Positive 55 (47.4) 61 (52.6) 116  
HER2 status     
Negative 14 (66.7) 7 (33.3) 21 0.206
Positive 79 (52.0) 73 (48.0) 152  
p53 status     
Negative 41 (50.0) 41 (50.0) 82 0.347
Positive 52 (57.1) 39 (42.9) 91  
  1. * P values are from χ2 test.
  2. Some cases were not available for the information.